400 related articles for article (PubMed ID: 15047799)
1. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.
Silverman LR; Phipps AJ; Montgomery A; Ratner L; Lairmore MD
J Virol; 2004 Apr; 78(8):3837-45. PubMed ID: 15047799
[TBL] [Abstract][Full Text] [Related]
2. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
Bartoe JT; Albrecht B; Collins ND; Robek MD; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Feb; 74(3):1094-100. PubMed ID: 10627519
[TBL] [Abstract][Full Text] [Related]
3. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II.
Lairmore MD; Albrecht B; D'Souza C; Nisbet JW; Ding W; Bartoe JT; Green PL; Zhang W
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1757-64. PubMed ID: 11080823
[TBL] [Abstract][Full Text] [Related]
5. Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.
Michael B; Nair AM; Datta A; Hiraragi H; Ratner L; Lairmore MD
Virology; 2006 Oct; 354(2):225-39. PubMed ID: 16890266
[TBL] [Abstract][Full Text] [Related]
6. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.
Valeri VW; Hryniewicz A; Andresen V; Jones K; Fenizia C; Bialuk I; Chung HK; Fukumoto R; Parks RW; Ferrari MG; Nicot C; Cecchinato V; Ruscetti F; Franchini G
Blood; 2010 Nov; 116(19):3809-17. PubMed ID: 20647569
[TBL] [Abstract][Full Text] [Related]
7. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.
Collins ND; Newbound GC; Albrecht B; Beard JL; Ratner L; Lairmore MD
Blood; 1998 Jun; 91(12):4701-7. PubMed ID: 9616168
[TBL] [Abstract][Full Text] [Related]
8. Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters.
Zhang W; Nisbet JW; Bartoe JT; Ding W; Lairmore MD
J Virol; 2000 Dec; 74(23):11270-7. PubMed ID: 11070026
[TBL] [Abstract][Full Text] [Related]
9. In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.
Silverman LR; Phipps AJ; Montgomery A; Fernandez S; Tsukahara T; Ratner L; Lairmore MD
Blood; 2005 Nov; 106(10):3602-8. PubMed ID: 16046523
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.
Datta A; Silverman L; Phipps AJ; Hiraragi H; Ratner L; Lairmore MD
Retrovirology; 2007 Jul; 4():49. PubMed ID: 17634129
[TBL] [Abstract][Full Text] [Related]
11. A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo.
Cockerell GL; Rovnak J; Green PL; Chen IS
Blood; 1996 Feb; 87(3):1030-5. PubMed ID: 8562927
[TBL] [Abstract][Full Text] [Related]
12. p30 protein: a critical regulator of HTLV-1 viral latency and host immunity.
Moles R; Sarkis S; Galli V; Omsland M; Purcell DFJ; Yurick D; Khoury G; Pise-Masison CA; Franchini G
Retrovirology; 2019 Dec; 16(1):42. PubMed ID: 31852501
[TBL] [Abstract][Full Text] [Related]
13. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
[TBL] [Abstract][Full Text] [Related]
14. Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.
Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA
J Virol; 2000 May; 74(9):3933-40. PubMed ID: 10756004
[TBL] [Abstract][Full Text] [Related]
15. Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes.
Michael B; Nair AM; Hiraragi H; Shen L; Feuer G; Boris-Lawrie K; Lairmore MD
Retrovirology; 2004 Nov; 1():39. PubMed ID: 15560845
[TBL] [Abstract][Full Text] [Related]
16. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.
Albrecht B; Lairmore MD
Microbiol Mol Biol Rev; 2002 Sep; 66(3):396-406, table of contents. PubMed ID: 12208996
[TBL] [Abstract][Full Text] [Related]
17. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.
Bindhu M; Nair A; Lairmore MD
Front Biosci; 2004 Sep; 9():2556-76. PubMed ID: 15358581
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.
Yamamoto B; Li M; Kesic M; Younis I; Lairmore MD; Green PL
Retrovirology; 2008 May; 5():38. PubMed ID: 18474092
[TBL] [Abstract][Full Text] [Related]
19. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.
Albrecht B; Collins ND; Burniston MT; Nisbet JW; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Nov; 74(21):9828-35. PubMed ID: 11024109
[TBL] [Abstract][Full Text] [Related]
20. Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.
Harrod R
Retrovirology; 2019 Sep; 16(1):25. PubMed ID: 31492165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
